Skip to main content
logo
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
10,280
+914 (9.76%)
Apr 29, 2026, 5:29 PM IDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue from Sale of Goods
-14.61B14.05B
Revenue from Sale of Goods Growth
-3.95%8.25%
Licensing Arrangements Revenue
-678.00M173.00M
Licensing Arrangements Revenue Growth
-291.91%-74.60%
Distribution Revenue
-1.55B1.58B
Distribution Revenue Growth
--1.59%-2.42%
Other Segment Revenue
-423.00M745.00M
Other Segment Revenue Growth
--43.22%30.70%
Revenue (Total)
17.35B17.26B16.54B
Revenue (Total) Growth
0.53%4.32%4.41%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States Revenue
8.81B9.19B8.03B
United States Revenue Growth
-4.08%14.34%3.92%
Europe Revenue
5.19B5.04B5.10B
Europe Revenue Growth
2.92%-1.23%5.50%
International Markets Revenue
2.10B2.16B2.46B
International Markets Revenue Growth
-2.68%-12.22%4.76%
Other Activities Revenue
-870.00M944.00M
Other Activities Revenue Growth
--7.84%1.94%
Revenue (Other)
1.25B--
Revenue (Total)
17.35B17.26B16.54B
Revenue (Total) Growth
0.53%4.32%4.41%

Adjusted EBIT by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States Segment Profit
3.33B3.36B2.30B
United States Segment Profit Growth
-0.74%46.17%-4.09%
Europe Segment Profit
1.38B1.30B1.58B
Europe Segment Profit Growth
5.53%-17.27%6.56%
International Markets Segment Profit
304.00M336.00M440.00M
International Markets Segment Profit Growth
-9.52%-23.64%-5.38%
Other Activities Segment Profit
--90.00M18.00M
Other Activities Segment Profit Growth
---25.00%
Operating Income (Total)
2.29B2.16B-303.00M
Operating Income (Total) Growth
6.12%--
Updated Mar 31, 2026. Data Source: Fiscal.ai.